Skip to main content
All lobbying filings

LMH STRATEGIC SOLUTIONS

LMH STRATEGIC SOLUTIONS filed a Q1 termination report for RARE DISEASE COMPANY COALITION on April 18, 2025, reporting $40,000 in lobbying income.

Lobbying for RARE DISEASE COMPANY COALITION · The Rare Disease Company Coalition

All filings by LMH STRATEGIC SOLUTIONS · Everything RARE DISEASE COMPANY COALITION has reported

 Filing · LD-2 quarterly report Q1 termination
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 18, 2025
Income
$40,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Representation ended
Mar 31, 2025
The registrant reported terminating its work for this client.

Official filing document

 Lobbyists on this filing 1
  • ALANNA TEMME
    Previously held: Legislative Director, U.S. Representative Jon Porter

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Issues will be pediatric review vouchers. Orphan drug tax credit.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem